{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:11:04Z","timestamp":1791396664516,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016879","name":"Union Chimique Belge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yebeh.2026.111244","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T18:59:38Z","timestamp":1785956378000},"page":"111244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond seizures in Dravet and Lennox\u2013Gastaut syndromes \u2212 An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine"],"prefix":"10.1016","volume":"184","author":[{"given":"Giancarlo","family":"Di Gennaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica Immacolata","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4293","authenticated-orcid":false,"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Messana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Trivisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111244_b0005","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s42399-021-00989-y","article-title":"Comorbidities in Dravet Syndrome and Lennox\u2013Gastaut Syndrome","volume":"3","author":"Marchese","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.yebeh.2026.111244_b0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/epi.16849","article-title":"The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results","volume":"62","author":"Johannessen Landmark","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111244_b0015","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.3390\/ijms22168416","article-title":"An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies","volume":"22","author":"Martin","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2026.111244_b0020","first-page":"2","article-title":"The Impact of Non-Seizure Symptoms in Dravet Syndrome and Lennox\u2013Gastaut Syndrome","volume":"12","author":"Cross","year":"2024","journal-title":"EMJ Neurol"},{"key":"10.1016\/j.yebeh.2026.111244_b0025","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/epi4.70118","article-title":"Nonseizure symptoms and broader seizure impacts in patients with Dravet syndrome and Lennox\u2013Gastaut syndrome in clinical practice settings: results from a multinational survey","volume":"10","author":"Shah","year":"2025","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111244_b0030","first-page":"42","article-title":"The burden of illness in Lennox-Gastaut syndrome: a systematic literature review n.d.;Orphanet","volume":"18","author":"Strzelczyk","year":"2023","journal-title":"J Rare Dis"},{"key":"10.1016\/j.yebeh.2026.111244_b0035","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Cognitive and Behavioral Co-Morbidities of Epilepsy","author":"Kleen","year":"2012"},{"key":"10.1016\/j.yebeh.2026.111244_b0040","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/epi4.13024","article-title":"Long-term outcomes and adaptive behavior in adult patients with Lennox-Gastaut syndrome","volume":"9","author":"Cerulli Irelli","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111244_b0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fneur.2017.00505","article-title":"Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations","volume":"8","author":"Cross","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111244_b0050","first-page":"134","article-title":"An italian consensus on the management of Lennox-Gastaut syndrome. Seizure: European","volume":"101","author":"Riva","year":"2022","journal-title":"J Epilepsy"},{"key":"10.1016\/j.yebeh.2026.111244_b0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/epi4.70290","article-title":"Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts","volume":"11","author":"Di Gennaro","year":"2026","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111244_b0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-023-01881-w","article-title":"Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes","volume":"83","author":"Frampton","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2026.111244_b0065","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2147\/NDT.S417676","article-title":"Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding","volume":"19","author":"Dini","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2026.111244_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1192022","article-title":"Fenfluramine: a plethora of mechanisms?","volume":"14","author":"Sourbron","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111244_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107280","article-title":"Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey","volume":"200","author":"Berg","year":"2024","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111244_b0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.seizure.2025.04.017","article-title":"Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged \u22652 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey","volume":"130","author":"Perry","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111244_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1332882","article-title":"Effects of vagus nerve stimulation on cognitive function in patients with epilepsy: a systematic review and meta-analysis","volume":"15","author":"Kong","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111244_b0090","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.18289","article-title":"Vagus nerve stimulation in Lennox\u2013Gastaut syndrome: Twenty\u2010four\u2010month data and experience from the CORE \u2010 VNS study","volume":"66","author":"Lyons","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111244_b0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13643-024-02738-3","article-title":"How Delphi studies in the health sciences find consensus: a scoping review","volume":"14","author":"Schifano","year":"2025","journal-title":"Syst Rev"},{"key":"10.1016\/j.yebeh.2026.111244_b0100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032829","article-title":"Use of Delphi in health sciences research: a narrative review","volume":"102","author":"Shang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.yebeh.2026.111244_b0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/WNL.0000000000002965","article-title":"The neurologist\u2019s role in supporting transition to adult health care: a consensus statement","volume":"87","author":"Brown","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111244_b0110","article-title":"Delphi consensus on the transition from paediatric to adult epilepsy care. Neurology","volume":"4","author":"Toledo","year":"2024","journal-title":"Perspectives"},{"key":"10.1016\/j.yebeh.2026.111244_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2025.1632564","article-title":"Organizational and behavioral models in the management of patients with developmental and epileptic encephalopathy, Lennox-Gastaut syndrome and Dravet syndrome in Italy: a focus on the transition from pediatric to adult care","volume":"5","author":"Di Bonaventura","year":"2025","journal-title":"Front Health Serv"},{"key":"10.1016\/j.yebeh.2026.111244_b0120","article-title":"Improving the transition from pediatric to adult epilepsy care: an expert opinion","volume":"172","author":"Villani","year":"2025","journal-title":"LTWA: Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111244_b0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/epi.17431","article-title":"Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox\u2013Gastaut syndrome: Interim analysis of an open\u2010label extension study","volume":"64","author":"Knupp","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111244_b0130","first-page":"554","article-title":"Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome: a Randomized Clinical Trial","volume":"79","author":"Knupp","year":"2022","journal-title":"LTWA: JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.111244_b0135","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1212\/WNL.0000000000202479","article-title":"Fenfluramine Treatment is Associated with Improvement in Everyday Executive Function in adults with Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects from a phase 3 Trial Rationale (P11-1.001)","volume":"100","author":"Bishop","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111244_b0140","article-title":"Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children\/young adults with Dravet syndrome","volume":"121","author":"Bishop","year":"2021","journal-title":"LTWA: Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111244_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107091","article-title":"Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom","volume":"190","author":"Jensen","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111244_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106976","article-title":"Fenfluramine treatment for dravet syndrome: Real-world benefits on quality of life from the caregiver perspective","volume":"185","author":"Jensen","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111244_b0155","article-title":"Beyond seizure control: Functional and caregiver-reported outcomes of long-term fenfluramine treatment in Dravet syndrome","volume":"180","author":"Massaroni","year":"2026","journal-title":"LTWA: Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111244_b0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40120-025-00713-1","article-title":"Expert-agreed Practical Recommendations on the use of Fenfluramine in Developmental and Epileptic Encephalopathies based on Clinical Experience and Literature Review","volume":"14","author":"Villanueva","year":"2025","journal-title":"Neurol Ther"},{"key":"10.1016\/j.yebeh.2026.111244_b0165","first-page":"1147","article-title":"New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025","volume":"25","author":"Dell\u2019Isola","year":"2025","journal-title":"LTWA: Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2026.111244_b0170","article-title":"Over twenty-five years of ketogenic diet therapy: supporting children and adults with drug-resistant epilepsy using nutritionally complete ketogenic formulations: a scoping review","volume":"172","author":"Carroll","year":"2025","journal-title":"LTWA: Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:33:04Z","timestamp":1789011184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026003653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":34,"alternative-id":["S1525505026003653"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111244","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond seizures in Dravet and Lennox\u2013Gastaut syndromes \u2212 An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111244"}}